Targeting gut and intratumoral microbiota: a novel strategy to improve therapy resistance in cancer with a focus on urologic tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting gut and intratumoral microbiota: a novel strategy to improve therapy resistance in cancer with a focus on urologic tumors

Published:2024-06-24 Issue:8 Volume:24 Page:747-759
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Wu Bingquan¹²,Quan Chao¹²,He Yunbo¹²,Matsika Juliet¹²,Huang Jinliang¹²,Liu Bolong¹²³,Chen Jinbo¹²^ORCID

Affiliation:

1. Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China

2. National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China

3. Department of Andrology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Hunan Province

Hunan Province Young talents Program

Central South University

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2024.2371543

Reference126 articles.

1. Extensive Unexplored Human Microbiome Diversity Revealed by Over 150,000 Genomes from Metagenomes Spanning Age, Geography, and Lifestyle

2. Interaction between drugs and the gut microbiome

3. Probiotics for cancer alternative prevention and treatment

4. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth

5. Microbiome harbored within tumors: a new chance to revisit our understanding of cancer pathogenesis and treatment

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP